Nothing Special   »   [go: up one dir, main page]

IN2013MU02286A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02286A
IN2013MU02286A IN2286MU2013A IN2013MU02286A IN 2013MU02286 A IN2013MU02286 A IN 2013MU02286A IN 2286MU2013 A IN2286MU2013 A IN 2286MU2013A IN 2013MU02286 A IN2013MU02286 A IN 2013MU02286A
Authority
IN
India
Prior art keywords
pharmaceutical
release
memantine
effective amount
time period
Prior art date
Application number
Inventor
Dutta Subhadeep
Kansagra Piyush
Singh Balvir
Sehgal Ashish
Original Assignee
Astron Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astron Res Ltd filed Critical Astron Res Ltd
Priority to IN2286MU2013 priority Critical patent/IN2013MU02286A/en
Publication of IN2013MU02286A publication Critical patent/IN2013MU02286A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This present invention relates to modified release pharmaceutical composition of memantine or its pharmaceutical!)' acceptable salts thereof and process for preparation of the same. The invention is particularly suitable for once-a-day solid oral pharmaceutical dosage forms, possessing improved formulation characteristics and release a therapeutically effective amount of the active ingredient over an extended time period.
IN2286MU2013 2013-07-08 2013-07-08 IN2013MU02286A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2286MU2013 IN2013MU02286A (en) 2013-07-08 2013-07-08

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2286MU2013 IN2013MU02286A (en) 2013-07-08 2013-07-08

Publications (1)

Publication Number Publication Date
IN2013MU02286A true IN2013MU02286A (en) 2015-06-19

Family

ID=54396531

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2286MU2013 IN2013MU02286A (en) 2013-07-08 2013-07-08

Country Status (1)

Country Link
IN (1) IN2013MU02286A (en)

Similar Documents

Publication Publication Date Title
MX2016010213A (en) Novel pharmaceutical formulations.
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
PH12015502802A1 (en) Formulation comprising a hypolipidemic agent
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
MX2021006969A (en) Peptide binder.
PH12015500823A1 (en) Modified release formulations for oprozomib
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
UA117154C2 (en) S1p3 antagonists
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
PH12015501945A1 (en) Formulations of organic compounds
CO2019006652A2 (en) Aromatic carboxylic acid amides as antagonists of the b1 bradykinin receptor
EA201991286A1 (en) A SOLID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING TENOFOVIR AND EMTRITSITABIN
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
ECSP16005208A (en) STABLE ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET INCLUDING ISONIAZID GRANULES AND RIFAPENTINE GRANULES AND THEIR PREPARATION PROCESS
SA516370446B1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
IN2013MU02286A (en)
PH12020500120A1 (en) Pharmaceutical compositions
IN2013MU02366A (en)
MX2015011099A (en) Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters.
GR1008819B (en) Pharmaceutical composition comprising atomoxetine and method for the preparation thereof
IN2013MU02442A (en)
EA201992754A1 (en) PHARMACEUTICAL COMPOSITIONS
TH132242B (en) Pharmaceutical components containing hydromorphs and analogue zones. (Pharmaceutical compositions comprising hydromorphone and naloxone)